Q2 2019 HLS Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Q2 Fiscal 2019 Financial Results Conference Call for HLS Therapeutics. On this morning's call, we have Greg Gubitz, Chief Executive Officer; Gilbert Godin, President and Chief Operating Officer; and Tim Hendrickson, Chief Financial Officer. (Operator Instructions)
Earlier this morning, HLS issued a news release announcing its financial results for the 3- and 6-month periods ending June 30, 2019. This news release, along with the company's MD&A and financial statements, will be available on HLS's website and on SEDAR.
Certain matters discussed in today's conference call or answers that may be given to questions could constitute forward-looking statements. Actual results could differ materially from those anticipated. Risk factors that could affect results are detailed in the company's annual information form dated April 1, 2019, which has been filed on SEDAR and can be accessed at www.sedar.com.
During this conference call, HLS will refer to adjusted EBITDA. Adjusted EBITDA does
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
